삼성서울병원

Ko En

폐식도외과분과 심영목 교수

진료분야
폐암, 식도암, 흉선종 및 종격동종양, 식도협착, 폐암수술, 식도암수술
진료일정 11 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
1994.02 서울대학교 대학원 흉부외과(의학박사)
1983.02 서울대학교 대학원 흉부외과(의학석사)
1979.02 서울대학교 의과대학 졸업(의학사)

경력

경력
2019.0301 ~현재 성균관대학교 의과대학 석좌교수
2018.0401 ~현재 삼성서울병원 환자중심 삶의질 연구소 소장
2004.04 ~현재 대한민국의학한림원 정회원
1994.04 ~현재 삼성서울병원 흉부외과 전문의
1997.03 ~ 2019.02 성균관대학교 의과대학 흉부외과 교수
2013.04 ~ 2015.03 삼성서울병원 암병원장
2007.09 ~ 2013.03 삼성서울병원 암센터장
2002.05 ~ 2007.08 성균관대학교 의과대학 흉부외과학학 교실 주임교수
2002.05 ~ 2007.08 삼성서울병원 흉부외과 과장
2000.04 ~ 2005.06 삼성서울병원 폐식도외과 과장
1999.04 ~ 2000.03 UNC Hospital Visiting Professor
1987.05 ~ 1994.03 원자력병원 흉부외과 과장
1991.09 ~ 1992.03 미국 M.D Anderson Cancer Center Visiting Doctor
1984.03 흉부외과 전문의 자격 취득
1980.03 ~ 1984.02 서울대학교병원 흉부외과 레지던트 과정 수료
1979.03 ~ 1980.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2004.04 ~ 현재 대한민국 의학한림원 정회원
2014.01 ~ 2016.12 대한암협회 집행이사
2004.01 ~ 2016.12 식도암연구회 회장
2014.01 ~ 2014.12 대한폐암학회 회장
2010.01 ~ 2014.12 보건복지부 암관리위원회 위원
2009.01 ~ 2011.12 대한흉부종양외과학회 회장
2005.11 ~ 2011.10 대한흉부외과학회 이사
2007.01 ~ 2008.12 대한기관식도학회 평의원
2003.01 ~ 2004.12 대한기관식도학회 평의원

수상이력

수상이력
2015.12 삼성서울병원 "올해의 교수상" 수상
2012.11 삼성 "자랑스런 삼성인상" 수상
2010.03 제3회 암 예방의날 대통령상 "국민포장" 수상
  • Gastrointest Endosc. 2018 Oct;88(4):624-633. doi: 10.1016/j.gie.2018.04.2360. Epub 2018 May 8. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis Min YW11, Lee H1, Song BG1, Min BH1, Kim HK2, Choi YS2, Lee JH1, Hwang NY3, Carriere KC4, Rhee PL1, Kim JJ1, Zo JI2, Shim YM2.
    View PubMed
  • Oncotarget. 2017 May 9;8(19):32201-32211. doi: 10.18632/oncotarget.12920. Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma Kim W11, Lee HY1, Jung SH2, Woo MA2, Kim HK3, Choi YS3, Kim J3, Zo JI3, Shim YM3, Han J4, Jeong JY4,5, Choi JY6, Lee KS1.
    View PubMed
  • J Thorac Oncol. 2017 Apr;12(4):624-632. doi: 10.1016/j.jtho.2016.11.2230. Epub 2016 Dec 5. Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma Song SH11, Park H2, Lee G3, Lee HY4, Sohn I5, Kim HS5, Lee SH6, Jeong JY7, Kim J8, Lee KS1, Shim YM8.
    View PubMed
  • Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer Jang HJ11,2,3, Lee HS1,2,4,5, Burt BM4, Lee GK5, Yoon KA5,6, Park YY2, Sohn BH2, Kim SB2, Kim MS1, Lee JM1, Joo J7, Kim SC8, Yun JS9, Na KJ9, Choi YL10, Park JL11, Kim SY11, Lee YS12, Han L13,14, Liang H13, Mak D15, Burks JK15, Zo JI16, Sugarbaker DJ4, Shim YM16, Lee JS2.
    View PubMed
  • Thorac Cancer. 2017 Jan;8(1):33-39. doi: 10.1111/1759-7714.12406. Epub 2016 Dec 7. Intensive care unit (ICU) readmission after major lung resection: Prevalence, patterns, and mortality Jung JJ11, Cho JH1, Hong TH1, Kim HK1, Choi YS1, Kim J1, Shim YM1, Zo JI1.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery Cho WK11, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):523-535. doi: 10.18632/oncotarget.13476. Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy ct images Bae JM11, Jeong JY2, Lee HY1, Sohn I3, Kim HS3, Son JY1, Kwon OJ4, Choi JY5, Lee KS1, Shim YM6.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14. Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease? Kim H11, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2193-2201. doi: 10.1016/j.jtho.2016.07.021. Epub 2016 Aug 4. Overexpression of beta-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim HK3, Kim DH4.
    View PubMed
  • Eur Respir J. 2016 Dec;48(6):1743-1750. doi: 10.1183/13993003.01148-2016. Epub 2016 Nov 3. Joint effect of airflow Limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer Shin S11, Park HY2,3, Kim H4, Kim HK1, Choi YS1, Kim J1, Um SW5, Chung MJ6, Kim H5, Kwon OJ5, Zo JI1, Guallar E4,7, Cho J4,7,8, Shim YM1,3.
    View PubMed
  • Lung Cancer. 2016 Nov;101:22-27. doi: 10.1016/j.lungcan.2016.06.021. Epub 2016 Sep 7. Limited thymectomy as a potential alternative treatment option for early-stage thymoma: A multi-institutional propensity-matched study Narm KS11, Lee CY1, Do YW1, Jung HS1, Byun GE1, Lee JG1, Kim DJ1, Hwang Y2, Park IK2, Kang CH2, Kim YT2, Cho JH3, Choi YS3, Kim J3, Shim YM3, Hwang SK4, Kim YH4, Kim DK4, Park SI4, Chung KY5; Korea Association for Research on the Thymus.
    View PubMed
  • Oncotarget. 2016 Oct 25;7(43):70353-70363. doi: 10.18632/oncotarget.11857. Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival Lee G11,2, Choi ER1, Lee HY1, Jeong JY3, Ahn JH4, Kim S4, Bae J1, Kim HK5, Choi YS5, Kim J5, Zo J5, Lee KS1, Shim YM5.
    View PubMed
  • Oncotarget. 2016 Oct 11;7(41):67302-67313. doi: 10.18632/oncotarget.11693. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma Choi ER11, Lee HY1, Jeong JY2, Choi YL3, Kim J4, Bae J1, Lee KS1, Shim YM4.
    View PubMed
  • Thorac Cardiovasc Surg. 2016 Oct;64(7):611-618. Epub 2016 May 5. Simultaneous Resection of Synchronous Esophageal and Gastric Cancers Park B11, Kim HK1, Choi YS1, Kim J1, Zo JI1, Shim YM1.
    View PubMed
  • Radiology. 2016 Aug;280(2):602-10. doi: 10.1148/radiol.2016151706. Epub 2016 Mar 4. Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome Cha MJ11, Lee KS1, Hwang HS1, Kim TJ1, Kim TS1, Kim BT1, Ko YH1, Shim YM1.
    View PubMed
  • BMC Cancer. 2016 Jul 20;16:505. doi: 10.1186/s12885-016-2504-x. Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer Yun YH11,2, Kim YA3, Sim JA4, Shin AS5, Chang YJ3, Lee J6, Kim MS6, Shim YM7, Zo JL7.
    View PubMed
  • J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas Lee HY11, Cha MJ1, Lee KS2, Lee HY1, Kwon OJ3, Choi JY4, Kim HK5, Choi YS5, Kim J5, Shim YM5.
    View PubMed
  • Thorac Cancer. 2016 Jul;7(4):393-8. doi: 10.1111/1759-7714.12354. Epub 2016 May 5. Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion Yoon DW11, Cho JH1, Choi YS1, Kim J1, Kim HK1, Zo JI1, Shim YM1.
    View PubMed
  • World J Surg Oncol. 2016 Jul 29;14(1):201. doi: 10.1186/s12957-016-0940-3. Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis Kim S11, Kim HK2, Cho JH1, Choi YS1, Kim K3, Kim J1, Zo JI1, Shim YM1, Heo JS4, Lee WY4, Kim HC4.
    View PubMed
  • J Thorac Oncol. 2016 Jul;11(7):1003-11. doi: 10.1016/j.jtho.2016.04.007. Epub 2016 Apr 18. Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases Sun JM11, Zhou W2, Choi YL1, Choi SJ1, Kim SE1, Wang Z2, Dolled-Filhart M2, Emancipator K2, Wu D2, Weiner R2, Frisman D3, Kim HK1, Choi YS1, Shim YM1, Kim J4.
    View PubMed
  • Eur Radiol. 2016 Jun;26(6):1538-46. doi: 10.1007/s00330-015-4029-0. Epub 2015 Oct 11. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma Song SH11, Ahn JH2, Lee HY3, Lee G4, Choi JY5, Kang J6, Kim EY1, Han J7, Kwon OJ8, Lee KS1, Kim HK9, Choi YS9, Kim J9, Shim YM9.
    View PubMed
  • Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease Kim HK11, Cho JH1, Choi YS1, Zo JI1, Shim YM1, Park K2, Ahn MJ2, Ahn YC3, Kim K4, Kim J5.
    View PubMed
  • Oncotarget. 2016 May 24;7(21):30691-701. doi: 10.18632/oncotarget.8749. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma Kim HS11, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Shim YM8, Jewell SS9, Kim H3, Choi YL10, Cho BC1.
    View PubMed
  • Medicine (Baltimore). 2016 Mar;95(12):e3109. doi: 10.1097/MD.0000000000003109. Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography Kim EY11, Hwang HS, Lee HY, Cho JH, Kim HK, Lee KS, Shim YM, Zo J.
    View PubMed
  • Support Care Cancer. 2016 Jan;24(1):295-9. doi: 10.1007/s00520-015-2776-8. Epub 2015 May 31. Clinical predictors of aspiration after esophagectomy in esophageal cancer patients Lee SY11, Cheon HJ1, Kim SJ1, Shim YM2, Zo JI2, Hwang JH3.
    View PubMed
  • Thorac Cancer. 2016 Jan;7(1):88-93. doi: 10.1111/1759-7714.12282. Epub 2015 Jun 5. Management of post-pneumonectomy syndrome using tissue expanders Jung JJ11, Cho JH1, Kim HK1, Choi YS1, Kim J1, Zo JI1, Shim YM1.
    View PubMed
  • Eur Radiol. 2016 Jan;26(1):43-54. doi: 10.1007/s00330-015-3816-y. Epub 2015 May 17. y Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping Son JY11, Lee HY2, Kim JH1, Han J3, Jeong JY3,4, Lee KS1, Kwon OJ5, Shim YM6.
    View PubMed
  • Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer Lim SH11, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.
    View PubMed
  • World J Surg Oncol. 2016 Jan 19;14(1):13. doi: 10.1186/s12957-015-0762-8. A retrospective comparative analysis of elderly and younger patients undergoing pulmonary resection for stage I non-small cell lung cancer Park B11, Lee G1, Kim HK1, Choi YS1, Zo JI1, Shim YM1, Kim J2.
    View PubMed
  • NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016 , 55(1):7-14, DOI: 10.3413/Nukmed-0754-15-07 Prognostic significance of volume-based F-18-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer Comparison with immunohistochemical biomarkers Lee JY1, Choi JY, Heo JH, Han J, Jang SJ, Kim K, Kim J, Shim YM, Kim BT
    View PubMed
  • BMC Cancer. 2015 Dec 17;15:982. doi: 10.1186/s12885-015-2001-7. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro Lee E11, Jin D2, Lee BB3, Kim Y4, Han J5, Shim YM6, Kim DH7,8.
    View PubMed
  • Ann Surg. 2015 Dec;262(6):965-71. doi: 10.1097/SLA.0000000000001039. New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma Lee GD11, Lee SE, Kim KM, Kim YH, Ahn JH, Jung S, Choi YL, Kim HR, Park SI, Shim YM.
    View PubMed
  • J Thorac Oncol. 2015 Dec;10(12):1785-94. doi: 10.1097/JTO.0000000000000689. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma Lee HY11, Lee SW, Lee KS, Jeong JY, Choi JY, Kwon OJ, Song SH, Kim EY, Kim J, Shim YM.
    View PubMed
  • Psychooncology. 2015 Dec;24(12):1723-30. doi: 10.1002/pon.3839. Epub 2015 May 26. Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT) Yun YH11,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.
    View PubMed
  • Ann Surg Oncol. 2015 Nov;22(12):4089-97. doi: 10.1245/s10434-015-4411-9. Epub 2015 Mar 18. Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung Yang HC11, Kim HR2, Jheon S3, Kim K1, Cho S1, Ahn S4, Lee HY5, Chung JH6, Chung KY7, Bae MK7, Park SY7, Kim DK2, Choi SH2, Zo JI8, Kim MS8, Lee JM8, Kim J9, Shim YM9, Na KJ10, Yun JS10, Park JY11.
    View PubMed
  • Thorac Cardiovasc Surg. 2015 Oct;63(7):583-8. doi: 10.1055/s-0034-1383813. Epub 2014 Jul 17. Central Lung Cancer Management: Impact of Bronchial Resection Margin Length Kim D11, Kim HK2, Choi YS2, Kim K3, Kim J2, Shim YM2.
    View PubMed
  • AJR Am J Roentgenol. 2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847. Volume-Based Assessment With F-18-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer Hyun SH11, Ahn HK2, Ahn MJ3, Ahn YC4, Kim J5, Shim YM5, Choi JY1.
    View PubMed
  • J Korean Med Sci. 2015 Aug;30(8):1085-91. doi: 10.3346/jkms.2015.30.8.1085. Epub 2015 Jul 15. Exuberant Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors Cha YJ11, Han J1, Lee KS2, Shim YM3.
    View PubMed
  • Korean J Radiol. 2015 Jul-Aug;16(4):929-35. doi: 10.3348/kjr.2015.16.4.929. Epub 2015 Jul 1. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using F-18-FDG PET/CT Park B11, Kim HK1, Choi YS1, Kim J1, Zo JI1, Choi JY2, Shim YM1.
    View PubMed
  • World J Surg Oncol. 2015 Jul 25;13:222. doi: 10.1186/s12957-015-0621-7. The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer Cho JH11, Kim S1, Namgung M1, Choi YS1, Kim HK1, Zo JI1, Shim YM1, Kim J2.
    View PubMed
  • Mol Carcinog. 2015 Jun;54 Suppl 1:E72-80. doi: 10.1002/mc.22180. Epub 2014 May 9. HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer Hwang JA11, Lee BB2, Kim Y2, Hong SH1, Kim YH3, Han J4, Shim YM5, Yoon CY1, Lee YS1, Kim DH2.
    View PubMed
  • Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):813-9. doi: 10.1093/icvts/ivv034. Epub 2015 Mar 3. Uniportal video-assisted thoracoscopic lobectomy: an alternative to conventional thoracoscopic lobectomy in lung cancer surgery Chung JH11, Choi YS2, Cho JH3, Kim HK3, Kim J3, Zo JI3, Shim YM3.
    View PubMed
  • Chest. 2015 May;147(5):1299-306. doi: 10.1378/chest.14-0717. Change of Junctions Between Stations 10 and 4 in the New International Association for the Study of Lung Cancer Lymph Node Map A Validation Study from a Single, Tertiary Referral Hospital Experience Lee S1, Lee HY, Lee KS, Yie M, Zo J, Shim YM, Han J, Ahn JH.
    View PubMed
  • Am J Surg Pathol. 2015 May;39(5):660-6. doi: 10.1097/PAS.0000000000000399. Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma Prognostic Significance and Survival Outcomes Lee G11, Lee HY, Jeong JY, Han J, Cha MJ, Lee KS, Kim J, Shim YM.
    View PubMed
  • Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30. Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy Lee HW11, Lee JI2, Lee SJ3, Cho HJ2, Song HJ4, Jeong da E5, Seo YJ2, Shin S5, Joung JG6, Kwon YJ7, Choi YL8, Park WY9, Lee HM10, Seol HJ2, Shim YM11, Joo KM12, Nam DH13.
    View PubMed
  • Oncotarget. 2015 Mar 10;6(7):5465-74. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR Ha SY11, Choi SJ2, Cho JH3, Choi HJ2, Lee J2, Jung K4, Irwin D5, Liu X6,7, Lira ME8, Mao M9, Kim HK3, Choi YS3, Shim YM3, Park WY10, Choi YL1,4,10, Kim J2,3.
    View PubMed
  • Clin Epigenetics. 2015 Mar 19;7(1):32. doi: 10.1186/s13148-015-0066-4. eCollection 2015. RAR beta 2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim DH4.
    View PubMed
  • Oncotarget. 2015 Feb 10;6(4):2562-72. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma Kim HS11, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Jung da H7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Moon YW1, Kim JH1, Shim YM8, Jewell SS9, Kim H3, Choi YL2, Cho BC1.
    View PubMed
  • J Thorac Oncol. 2015 Feb;10(2):331-7. doi: 10.1097/JTO.0000000000000388. Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non-Small-Cell Lung Cancer Um SW11, Kim HK, Jung SH, Han J, Lee KJ, Park HY, Choi YS, Shim YM, Ahn MJ, Park K, Ahn YC, Choi JY, Lee KS, Suh GY, Chung MP, Kwon OJ, Kim J, Kim H.
    View PubMed
  • Ann Thorac Surg. 2015 Feb;99(2):462-70. doi: 10.1016/j.athoracsur.2014.09.050. Epub 2014 Dec 20. Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings Moon JW11, Lee KS2, Shin MH3, Kim S4, Woo SY4, Lee G5, Han J6, Shim YM7, Choi YS7.
    View PubMed
  • Ann Thorac Surg. 2015 Jan;99(1):218-22. doi: 10.1016/j.athoracsur.2014.07.068. Epub 2014 Nov 15. Long-Term Outcomes of Wedge Resection for Pulmonary Ground-Glass Opacity Nodules Cho JH11, Choi YS2, Kim J1, Kim HK1, Zo JI1, Shim YM1.
    View PubMed
  • Cancer Chemother Pharmacol. 2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery Lim HJ11, Lee HY, Lee KS, Han J, Kwon OJ, Park K, Ahn YC, Kim BT, Shim YM.
    View PubMed
  • Thorac Cardiovasc Surg. 2014 Oct;62(7):616-23. doi: 10.1055/s-0033-1363767. Epub 2014 Apr 20. Approach to Metastasis-Suspected Nodule Accompanying Operable Non-Small Cell Lung Cancer Shin S11, Park JS2, Kim HK1, Choi YS1, Shim YM1, Lee HY3, Kim J1.
    View PubMed
  • Chyle leakage patterns and management after oncologic esophagectomy: A retrospective cohort study
  • J Surg Oncol. 2014 Sep;110(3):239-44. doi: 10.1002/jso.23643. Epub 2014 May 29. Carinal Resection and Reconstruction in Thoracic Malignancies Shin S11, Park JS, Shim YM, Kim HJ, Kim J.
    View PubMed
  • J Thorac Dis. 2014 Sep;6(9):1225-9. doi: 10.3978/j.issn.2072-1439.2014.08.19. Is video-assisted thoracic surgery lobectomy in benign disease practical and effective Kim D11, Kim HK1, Choi YS1, Kim J1, Shim YM1, Kim K1.
    View PubMed
  • Eur J Cardiothorac Surg. 2014 Aug;46(2):274-9; discussion 279. doi: 10.1093/ejcts/ezt607. Epub 2014 Mar 14. Clinical stage T1-T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis Shin S11, Kim HK1, Choi YS1, Kim K2, Shim YM3.
    View PubMed
  • PLoS One. 2014 Aug 7;9(8):e104066. doi: 10.1371/journal.pone.0104066. eCollection 2014. Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma Son JY11, Lee HY1, Lee KS1, Kim JH1, Han J2, Jeong JY2, Kwon OJ3, Shim YM4.
    View PubMed
  • J Clin Pathol. 2014 Jul;67(7):587-91. doi: 10.1136/jclinpath-2013-202107. Epub 2014 Apr 16. Reliability of small biopsy or cytology for the diagnosis of pulmonary mucinous adenocarcinoma Lee HY11, Lee HY1, Lee KS1, Kwon OJ2, Shim YM3, Han J4.
    View PubMed
  • Ann Surg Oncol. 2014 Jun;21(6):2083-90. doi: 10.1245/s10434-014-3540-x. Epub 2014 Feb 13. Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy Lee H11, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.
    View PubMed
  • J Nucl Med. 2014 May;55(5):743-8. doi: 10.2967/jnumed.113.130716. Epub 2014 Apr 3. Prediction of Occult Lymph Node Metastasis by Metabolic Parameters in Patients with Clinically N0 Esophageal Squamous Cell Carcinoma Moon SH11, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY.
    View PubMed
  • Ann Surg. 2014 Mar;259(3):569-75. doi: 10.1097/SLA.0b013e318291db9d. Employment Status and Work-Related Difficulties in Lung Cancer Survivors Compared With the General Population Kim YA11, Yun YH, Chang YJ, Lee J, Kim MS, Lee HS, Zo JI, Kim J, Choi YS, Shim YM, Yoon SJ.
    View PubMed
  • AJR Am J Roentgenol. 2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819. Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management Lee HY11, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW.
    View PubMed
  • J Thorac Cardiovasc Surg. 2014 Mar;147(3):921-928.e2. doi: 10.1016/j.jtcvs.2013.09.045. Epub 2013 Nov 4. Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome Cha MJ11, Lee HY2, Lee KS1, Jeong JY3, Han J3, Shim YM4, Hwang HS1.
    View PubMed
  • Thorac Cardiovasc Surg. 2014 Mar;62(2):103-8. doi: 10.1055/s-0032-1333067. Epub 2013 Jan 14. Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer Kim D11, Choi YS1, Kim HK1, Kim K2, Kim J1, Shim YM1.
    View PubMed
  • PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014. Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy Chong Y11, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.
    View PubMed
  • Ann Thorac Surg. 2014 Feb;97(2):454-9. doi: 10.1016/j.athoracsur.2013.10.030. Epub 2013 Dec 17. Enucleation of Esophageal Submucosal Tumors: A Single Institution's Experience Shin S11, Choi YS2, Shim YM1, Kim HK1, Kim K3, Kim J1.
    View PubMed
  • J Clin Oncol. 2014 Jan 10;32(2):121-8. doi: 10.1200/JCO.2013.50.8556. Epub 2013 Dec 9. Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients Kim Y11, Hammerman PS, Kim J, Yoon JA, Lee Y, Sun JM, Wilkerson MD, Pedamallu CS, Cibulskis K, Yoo YK, Lawrence MS, Stojanov P, Carter SL, McKenna A, Stewart C, Sivachenko AY, Oh IJ, Kim HK, Choi YS, Kim K, Shim YM, Kim KS, Song SY, Na KJ, Choi YL, Hayes DN, Kim J, Cho S, Kim YC, Ahn JS, Ahn MJ, Getz G, Meyerson M, Park K.
    View PubMed
  • Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):50-8. doi: 10.1007/s00259-013-2530-8. Epub 2013 Aug 16. Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer Hyun SH11, Ahn HK, Kim H, Ahn MJ, Park K, Ahn YC, Kim J, Shim YM, Choi JY.
    View PubMed
  • Oncotarget. 2013 Dec;4(12):2317-25. HOXA11 hypermethylation is associated with progression of non-small cell lung cancer Hwang JA11, Lee BB, Kim Y, Park SE, Heo K, Hong SH, Kim YH, Han J, Shim YM, Lee YS, Kim DH.
    View PubMed
  • Clin Cancer Res. 2013 Nov 1;19(21):5879-89. doi: 10.1158/1078-0432.CCR-13-1181. Epub 2013 Aug 30. Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma Lee HW11, Park YM, Lee SJ, Cho HJ, Kim DH, Lee JI, Kang MS, Seol HJ, Shim YM, Nam DH, Kim HH, Joo KM.
    View PubMed
  • PLoS One. 2013 Nov 12;8(11):e79634. doi: 10.1371/journal.pone.0079634. eCollection 2013. Epigenetic Inactivation of Heparan Sulfate (Glucosamine) 3-O-Sulfotransferase 2 in Lung Cancer and Its Role in Tumorigenesis Hwang JA11, Kim Y, Hong SH, Lee J, Cho YG, Han JY, Kim YH, Han J, Shim YM, Lee YS, Kim DH.
    View PubMed
  • Eur J Cardiothorac Surg. 2013 Sep;44(3):520-4. doi: 10.1093/ejcts/ezt058. Epub 2013 Mar 15. Outcome of free jejunal transfer using the end-to-side arterial anastomosis technique as a pharyngo-oesophageal substitute: a 15-year experience Kim SH11, Kim HK, Kim K, Shim YM.
    View PubMed
  • Ann Oncol. 2013 Jun;24(6):1552-9. doi: 10.1093/annonc/mdt032. Epub 2013 Mar 6. Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer Yun YH11, Shon EJ, Yang AJ, Kim SH, Kim YA, Chang YJ, Lee J, Kim MS, Lee HS, Zo JI, Kim J, Choi YS, Shim YM.
    View PubMed
  • Lung Cancer. 2013 May;80(2):191-6. doi: 10.1016/j.lungcan.2013.01.009. Epub 2013 Feb 4. Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer Sun JM11, Rampal S, Lee G, Lee J, Choi YL, Parasuraman B, Guallar E, Cho J, Shim YM.
    View PubMed
  • Cancer. 2013 May 1;119(9):1752-60. doi: 10.1002/cncr.27948. Epub 2013 Jan 10. Cohypermethylation of p14 in Combination With CADM1 or DCC as a Recurrence-Related Prognostic Indicator in Stage I Esophageal Squamous Cell Carcinoma Lee E11, Lee BB, Ko E, Kim Y, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Dis Esophagus. 2013 Apr;26(3):272-5. doi: 10.1111/j.1442-2050.2012.01361.x. Epub 2012 May 29. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma Shim YM11, Park JS, Lee M, Kim D, Kim K.
    View PubMed
  • Psychooncology. 2013 Mar;22(3):605-13. doi: 10.1002/pon.3041. Epub 2012 Feb 16. Public attitudes toward cancer and cancer patients: a national survey in Korea Cho J11, Smith K, Choi EK, Kim IR, Chang YJ, Park HY, Guallar E, Shim YM.
    View PubMed
  • Cancer Res Treat. 2013 Mar;45(1):22-30. doi: 10.4143/crt.2013.45.1.22. Epub 2013 Mar 31. Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma Park JS11, Choi JY, Moon SH, Ahn YC, Lee J, Kim D, Kim K, Shim YM.
    View PubMed
  • Ann Surg Oncol. 2013 Mar;20(3):1005-12. doi: 10.1245/s10434-012-2727-2. Epub 2012 Nov 1. Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer Ko E11, Kim Y, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14. Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer Ko E11, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • PLoS One. 2013;8(2):e56011. doi: 10.1371/journal.pone.0056011. Epub 2013 Feb 28. EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital Choi YL11, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM.
    View PubMed
  • Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer Ko E11, Kim Y, Park SE, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Ann Thorac Surg. 2012 Jul;94(1):337; author reply 337-8. doi: 10.1016/j.athoracsur.2012.01.033. Complication Rates in Mediastinoscopy and Training: Video Versus Conventional Mediastinoscopy Reply Zakkar M1, Hunt I.
    View PubMed
  • Ann Surg. 2012 May;255(5):1000-7. doi: 10.1097/SLA.0b013e31824f1e9e. Health-Related Quality of Life in Disease-Free Survivors of Surgically Treated Lung Cancer Compared With the General Population Yun YH11, Kim YA, Min YH, Chang YJ, Lee J, Kim MS, Lee HS, Kim J, Choi YS, Shim YM, Zo JI.
    View PubMed
  • J Clin Oncol. 2012 Apr 20;30(12):1296-303. doi: 10.1200/JCO.2011.37.2979. Epub 2012 Mar 12. Web-Based Tailored Education Program for Disease-Free Cancer Survivors With Cancer-Related Fatigue: A Randomized Controlled Trial Yun YH11, Lee KS, Kim YW, Park SY, Lee ES, Noh DY, Kim S, Oh JH, Jung SY, Chung KW, Lee YJ, Jeong SY, Park KJ, Shim YM, Zo JI, Park JW, Kim YA, Shon EJ, Park S.
    View PubMed
  • Eur J Cardiothorac Surg. 2012 Jan;41(1):41-5. doi: 10.1016/j.ejcts.2011.03.051. Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma - a single-institutional experience Park JS11, Lee M, Kim HK, Choi YS, Kim K, Kim J, Kim H, Shim YM.
    View PubMed
  • Eur J Cardiothorac Surg. 2011 Nov;40(5):1181-4. doi: 10.1016/j.ejcts.2011.02.061. Epub 2011 Aug 24. Primary gastric cancer in an oesophageal gastric graft after oesophagectomy Yoon YS11, Kim HK, Choi YS, Kim K, Kim J, Shim YM.
    View PubMed
  • Ann Thorac Surg. 2011 Sep;92(3):1007-11. doi: 10.1016/j.athoracsur.2011.02.032. Epub 2011 May 20. A Comparative Analysis of Video-Assisted Mediastinoscopy and Conventional Mediastinoscopy Cho JH11, Kim J, Kim K, Choi YS, Kim HK, Shim YM.
    View PubMed
  • Cancer. 2011 Sep 1;117(17):4080-91. doi: 10.1002/cncr.25930. Epub 2011 Feb 24. A Functional Single Nucleotide Polymorphism at the Promoter Region of Cyclin A2 Is Associated With Increased Risk of Colon, Liver, and Lung Cancers Kim DH11, Park SE, Kim M, Ji YI, Kang MY, Jung EH, Ko E, Kim Y, Kim S, Shim YM, Park J.
    View PubMed
  • Oncology. 2011;81(3-4):206-13. doi: 10.1159/000333095. Epub 2011 Nov 9. Clinicopathologic Outcomes of Curative Resection for Sarcomatoid Carcinoma of the Lung Park JS11, Lee Y, Han J, Kim HK, Choi YS, Kim J, Shim YM, Kim K.
    View PubMed
  • World J Surg. 2011 Mar;35(3):590-5. doi: 10.1007/s00268-010-0913-6. Unplanned Conversion to Thoracotomy During Video-Assisted Thoracic Surgery Lobectomy does not Compromise the Surgical Outcome Park JS11, Kim HK, Choi YS, Kim J, Shim YM, Kim K.
    View PubMed
  • Ann Surg Oncol. 2010 Oct;17(10):2795-801. doi: 10.1245/s10434-010-1073-5. Epub 2010 Jun 2. Long-Term Survival and Prognostic Factors after Pulmonary Metastasectomy in Hepatocellular Carcinoma Yoon YS11, Kim HK, Kim J, Choi YS, Shim YM, Paik SW, Kim K.
    View PubMed
  • Ann Thorac Surg. 2010 Jun;89(6):S2118-22. doi: 10.1016/j.athoracsur.2010.03.017. Video-Assisted Thoracic Surgery Lobectomy: Single Institutional Experience With 704 Cases Kim K11, Kim HK, Park JS, Chang SW, Choi YS, Kim J, Shim YM.
    View PubMed
  • J Thorac Oncol. 2010 May;5(5):707-12. doi: 10.1097/JTO.0b013e3181d3ccb2. Comparison of Survival and Recurrence Pattern Between Two-Field and Three-Field Lymph Node Dissections for Upper Thoracic Esophageal Squamous Cell Carcinoma Shim YM11, Kim HK, Kim K.
    View PubMed
  • Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):566-73. doi: 10.1158/1055-9965.EPI-09-0980. Association of Global Levels of Histone Modifications with Recurrence-Free Survival in Stage IIB and III Esophageal Squamous Cell Carcinomas I H11, Ko E, Kim Y, Cho EY, Han J, Park J, Kim K, Kim DH, Shim YM.
    View PubMed
  • Cancer Lett. 2009 Feb 18;274(2):225-32. doi: 10.1016/j.canlet.2008.09.016. Epub 2008 Oct 19. Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer Ko E11, Kim Y, Lee BB, Han J, Song SY, Shim YM, Park J, Kim DH.
    View PubMed
  • Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha 4 is associated with recurrence of early stage esophageal squamous cell carcinoma Lee EJ11, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.
    View PubMed
  • Lung Cancer. 2007 Dec;58(3):342-7. Epub 2007 Sep 7. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer Kim HK11, Choi YS, Kim K, Kim J, Shim YM.
    View PubMed
  • J Thorac Cardiovasc Surg. 2007 Aug;134(2):411-4. Long-term results of surgical treatment in benign bronchoesophageal fistula Kim HK11, Choi YS, Kim K, Kim J, Shim YM.
    View PubMed
  • J Cancer Res Clin Oncol. 2007 Apr;133(4):219-26. Epub 2006 Oct 20. Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer Kwon YM11, Park JH, Kim H, Shim YM, Kim J, Han J, Park J, Kim DH.
    View PubMed
  • J Korean Med Sci. 2006 Aug;21(4):749-51. Giant fibrovascular polyp of the hypopharynx: Surgical treatment with the biappoach I H11, Kim JS, Shim YM.
    View PubMed
  • Eur J Cancer. 2006 May;42(7):972-80. Epub 2006 Mar 27. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma Lee EJ11, Lee BB, Kim JW, Shim YM, Hoseok I, Han J, Cho EY, Park J, Kim DH.
    View PubMed
  • Cancer Res. 2006 Apr 15;66(8):4049-54. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer Kim JS11, Kim JW, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Ann Thorac Surg. 2006 Feb;81(2):712-4. Pharyngo-colostomy with supraglottic partial laryngectomy in caustic oropharyngeal stricture Hoseok I11, Shim YM, Son YI, Kim K, Choi YS.
    View PubMed
  • Cancer. 2005 Nov 1;104(9):1825-33. Aberrant methylation of H-Cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma Kim JS11, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • J Korean Med Sci. 2005 Apr;20(2):229-31. Prognosis after surgical resection of M1a/M1b esophageal squamous cell carcinoma Shim YM11, Choi YS, Kim K.
    View PubMed
  • Carcinogenesis. 2004 Nov;25(11):2165-71. Epub 2004 Jul 1. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung Kim JS11, Kim H, Shim YM, Han J, Park J, Kim DH.
    View PubMed
  • J Clin Oncol. 2004 Sep 1;22(17):3443-50. Epub 2004 Jul 26. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer Kim JS11, Lee H, Kim H, Shim YM, Han J, Park J, Kim DH.
    View PubMed
  • Cancer Res. 2003 Oct 1;63(19):6206-11. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer Kim DH11, Kim JS, Park JH, Lee SK, Ji YI, Kwon YM, Shim YM, Han J, Park J.
    View PubMed
  • Cancer Res. 2003 Jul 1;63(13):3743-6. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer Kim DH11, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.
    View PubMed
  • Ann Thorac Surg. 2003 Feb;75(2):364-6. Mediastinoscopy in patients with clinical stage I non-small cell lung cancer Choi YS11, Shim YM, Kim J, Kim K.
    View PubMed
  • Eur J Cardiothorac Surg. 2002 Nov;22(5):695-700. Recurrence-free survival and prognostic factors in resected PN2 non-small cell lung cancer Choi YS11, Shim YM, Kim J, Kim K.
    View PubMed
  • Ann Thorac Surg. 2001 Jan;71(1):290-4. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography Kim K11, Park SJ, Kim BT, Lee KS, Shim YM.
    View PubMed